These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8148237)

  • 1. Aqueous humor inhibits epidermal cell antigen-presenting function.
    Hosoi J; Grabbe S; Knisely TL; Granstein RD
    Reg Immunol; 1993; 5(5):279-84. PubMed ID: 8148237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells.
    Beissert S; Hosoi J; Grabbe S; Asahina A; Granstein RD
    J Immunol; 1995 Feb; 154(3):1280-6. PubMed ID: 7822797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of biologically significant concentrations of glucocorticoids but little or no cortisol binding globulin within aqueous humor: relevance to immune privilege in the anterior chamber of the eye.
    Knisely TL; Hosoi J; Nazareno R; Granstein RD
    Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3711-23. PubMed ID: 8088958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal cell presentation of tumor-associated antigens for induction of tolerance.
    Tan KC; Hosoi J; Grabbe S; Asahina A; Granstein RD
    J Immunol; 1994 Jul; 153(2):760-7. PubMed ID: 7912706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of tumor antigen presentation by urocanic acid.
    Beissert S; Mohammad T; Torri H; Lonati A; Yan Z; Morrison H; Granstein RD
    J Immunol; 1997 Jul; 159(1):92-6. PubMed ID: 9200443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific aqueous humor factors induce activation of regulatory T cells.
    Nishida T; Taylor AW
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2268-74. PubMed ID: 10476792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta.
    Wilbanks GA; Streilein JW
    Eur J Immunol; 1992 Apr; 22(4):1031-6. PubMed ID: 1551403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide.
    Asahina A; Hosoi J; Beissert S; Stratigos A; Granstein RD
    J Immunol; 1995 Apr; 154(7):3056-61. PubMed ID: 7897198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type.
    Hara Y; Okamoto S; Rouse B; Streilein JW
    J Immunol; 1993 Nov; 151(10):5162-71. PubMed ID: 8228216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of cyclosporine on epidermal cells. I. Cyclosporine inhibits accessory cell functions of epidermal Langerhans cells in vitro.
    Furue M; Katz SI
    J Immunol; 1988 Jun; 140(12):4139-43. PubMed ID: 3259608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel role for TGF-beta and IL-10 in the induction of immune privilege.
    D'Orazio TJ; Niederkorn JY
    J Immunol; 1998 Mar; 160(5):2089-98. PubMed ID: 9498745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye.
    Apte RS; Niederkorn JY
    J Immunol; 1996 Apr; 156(8):2667-73. PubMed ID: 8609381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor antigen presentation by murine epidermal cells.
    Grabbe S; Bruvers S; Gallo RL; Knisely TL; Nazareno R; Granstein RD
    J Immunol; 1991 May; 146(10):3656-61. PubMed ID: 2026885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine IL-10 partially prevents differentiation of neonatal dendritic epidermal leukocytes into Langerhans cells.
    Chang-Rodriguez S; Ecker R; Stingl G; Elbe-Bürger A
    J Leukoc Biol; 2004 Sep; 76(3):657-66. PubMed ID: 15197230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal Langerhans' cell induction of immunity against an ultraviolet-induced skin tumour.
    Cavanagh LL; Sluyter R; Henderson KG; Barnetson RS; Halliday GM
    Immunology; 1996 Mar; 87(3):475-80. PubMed ID: 8778036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fresh and cultured Langerhans cells display differential capacities to activate hapten-specific T cells.
    Dai R; Grammer SF; Streilein JW
    J Immunol; 1993 Jan; 150(1):59-66. PubMed ID: 8417131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aqueous humor contains transforming growth factor-beta and a small (less than 3500 daltons) inhibitor of thymocyte proliferation.
    Granstein RD; Staszewski R; Knisely TL; Zeira E; Nazareno R; Latina M; Albert DM
    J Immunol; 1990 Apr; 144(8):3021-7. PubMed ID: 2324494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supernatants from UVB radiation-exposed keratinocytes inhibit Langerhans cell presentation of tumor-associated antigens via IL-10 content.
    Beissert S; Ullrich SE; Hosoi J; Granstein RD
    J Leukoc Biol; 1995 Aug; 58(2):234-40. PubMed ID: 7643016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 1 alpha but not transforming growth factor beta inhibits tumor antigen presentation by epidermal antigen-presenting cells.
    Grabbe S; Bruvers S; Granstein RD
    J Invest Dermatol; 1994 Jan; 102(1):67-73. PubMed ID: 8288913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6 antagonizes TGF-beta and abolishes immune privilege in eyes with endotoxin-induced uveitis.
    Ohta K; Yamagami S; Taylor AW; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2591-9. PubMed ID: 10937571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.